Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
107 studies found for:    hemophilia | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
hemophilia | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia
Condition: Haemophilia A
Intervention: Other: Thrombin generation measurement.
2 Recruiting Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
Condition: Haemophilia
Intervention: Other: Patients with haemophilia
3 Recruiting The Hemophilia Ultrasound Project
Conditions: Hemophilia A;   Hemophilia B
Interventions: Other: Ankle and Knee Ultrasound Joint Assessment;   Other: Ankle and Knee Magnetic Resonance Imaging
4 Not yet recruiting Hemophilia Inhibitor Prevention (INHIBIT) Trial
Condition: Severe Hemophilia A
Intervention: Drug: Long-acting recombinant factor VIII Fc fusion protein
5 Recruiting Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia
Condition: Hemophilia
Intervention:
6 Recruiting Adherence to Treatment in Hemophilia
Condition: Haemophilia
Intervention:
7 Not yet recruiting Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?
Condition: Hemophilia
Interventions: Device: Chronometric method;   Device: Chromogenic method;   Device: Thrombin generation test (TGT)
8 Recruiting Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
Condition: Hemophilia A
Intervention: Drug: Available Recombinant, and Human Factor VIII products incl. Kogenate FS (Recombinant Factor VIII, BAY14-2222)
9 Recruiting Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.
Condition: Hemophilia A
Intervention: Other: Endurance training program
10 Recruiting Factor Product Utilization and Health Outcomes in Patients With Hemophilia
Conditions: Hemophilia A, Congenital;   Hemophilia B, Congenital
Intervention:
11 Recruiting Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
12 Recruiting A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN 2)
Condition: Hemophilia A
Intervention: Drug: Emicizumab
13 Recruiting Weight-based Dosing in Hemophilia A
Condition: Hemophilia
Intervention: Drug: rFVIII
14 Recruiting National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Behavioral: Educational Package
15 Recruiting Hemophilia Inhibitor Previously Untreated Patient Study
Condition: Hemophilia A
Intervention: Drug: FVIII concentrate
16 Not yet recruiting German Pediatric Hemophilia Research Database
Conditions: Hemophilia A;   Hemophilia B;   Children;   Drug Specific Antibodies
Intervention: Other: documentation only
17 Recruiting ATHN 2: Factor Switching Study
Condition: Hemophilia
Interventions: Biological: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013;   Biological: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
18 Not yet recruiting PF-06741086 Multiple Dose Study in Severe Hemophilia
Condition: Hemophilia A or B
Intervention: Biological: PF-06741086
19 Recruiting Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
Condition: Hemophilia A
Intervention: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
20 Recruiting Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: AAV5-hFIX

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.